Rodger Novak

Co-Founder and President, CRISPR Therapeutics

Rodger is one of the three co-founders of CRISPR Therapeutics, which aims to treat diseases using CRISPR/Cas9 gene editing technology. The company recently announced that the first patients had been treated with CTX001, a CRISPR/Cas9 therapy β-thalassemia and sickle cell disease.

Part of the Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019